ziftomenib,daunorubicin,azacitidine,venetoclax,cytarabine
kura oncology,roche,abbvie
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'komet-001', 'ko,met,01', 'ko,met,001', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'ziftomenib']
congress #eha2023 | amir fathi presents ph 1 komet-001 study results showing ziftomenib was well tolerated in pts with r/r npm1-m #aml. ds events were clinical manageable. cr was 35%; median dor was 8.2 mo with mrd clearance of npm1-m &amp; key co-mutations.
#leusm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm